Opportunity Information: Apply for HRSA 10 090
Apply for HRSA 10 090
- The Health Resources and Services Administration in the health sector is offering a public funding opportunity titled "Hepatitis C Treatment Expansion Initiative Demonstration Sites" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.928 Special Projects of National Significance.
- This funding opportunity was created on Apr 16, 2010 and posted on Mar 4, 2010.
- Applicants must submit their applications by Apr 20, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,220,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 15 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible applicants include Ryan White HIV/AIDS Program Grantees under Parts A, B, C and D with experience in delivering core medical services including HIV primary care services and allowable support services to HIV positive, underserved individuals. Subcontractors or sub providers receiving Ryan White funding from one or more of the above entities are eligible to apply. Due to the need to maximize limited resources, grantees that are currently actively incorporating HCV treatment in the context of HIV primary care using Ryan White funding or are currently receiving funding from another entity for similar work are not eligible under this program.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Hepatitis C Treatment Expansion Initiative Demonstration Sites grant (Funding Opportunity Number HRSA 10-090) is a Health Resources and Services Administration (HRSA) discretionary grant designed to help Ryan White HIV/AIDS Program providers expand access to Hepatitis C (HCV) treatment for people living with HIV. The central idea is to move proven HCV treatment approaches into everyday Ryan White-funded HIV primary care settings, since HCV treatment has historically been underused because many clinics lack the staffing, resources, infrastructure, or clinical capacity to offer it routinely. Through this initiative, HRSA's HIV/AIDS Bureau intends not only to increase the number of sites that can deliver HCV treatment within HIV care, but also to identify what implementation strategies work best in real-world Ryan White clinical environments.
Funding supports organizations that will implement and evaluate existing successful HCV treatment interventions or care models within Ryan White-funded HIV primary care. The program is structured as a set of demonstration sites, meaning awardees are expected to do more than provide services: they must also generate evidence and practical guidance that other Ryan White providers can use. Participating sites are required to engage in both local and multi-site evaluations, collecting process and outcome data and other relevant information that shows how well the adopted model performs in a Ryan White primary care context. This includes gathering information on effectiveness and costs, with the expectation that the results will help the broader Ryan White community understand the resources required, operational steps involved, and clinical outcomes achieved when HCV treatment is integrated into HIV care.
A major deliverable for applicants is a strong plan to document their approach in a way that can be replicated. Applicants must propose how they will compile lessons learned and clearly describe best practice models that can be shared with other Ryan White grantees and HIV medical providers to improve access to HCV treatment and strengthen the overall quality of Ryan White services for underserved people living with HIV. In addition, applicants need a practical dissemination plan for providing complete documentation of their best practice model to HRSA's HIV/AIDS Bureau and sharing it nationally across the Ryan White community, with the explicit goal of supporting replication and integration into other sites.
Eligibility is limited to Ryan White HIV/AIDS Program grantees funded under Parts A, B, C, and D, as well as subcontractors or subproviders that receive Ryan White funding through those entities. Eligible applicants must have experience delivering core medical services, including HIV primary care, and allowable support services to HIV-positive underserved individuals. To stretch limited resources and focus on expansion where it is most needed, the announcement excludes organizations that are already actively incorporating HCV treatment into HIV primary care using Ryan White funds, or that are already receiving other funding for similar HCV-in-HIV treatment integration work.
The opportunity anticipated making 15 awards with an estimated total funding amount of $1,220,000, with no cost sharing or matching requirement. It is associated with CFDA number 93.928 (Special Projects of National Significance). Key dates listed include a posted date of March 4, 2010, an original closing date of April 5, 2010, and a revised closing date of April 20, 2010, with an archive date of June 19, 2010. For access issues or administrative questions, applicants were directed to the HRSA Call Center (CallCenter@HRSA.GOV) and the listed phone numbers.
FAQs: Hepatitis C Treatment Expansion Initiative Demonstration Sites (HRSA 10-090)
What is the Hepatitis C Treatment Expansion Initiative Demonstration Sites grant (HRSA 10-090)?
This is a Health Resources and Services Administration (HRSA) discretionary grant designed to help Ryan White HIV/AIDS Program providers expand access to Hepatitis C (HCV) treatment for people living with HIV by integrating proven HCV treatment approaches into routine Ryan White-funded HIV primary care settings.
What is the main goal of this funding opportunity?
The central goal is to move proven HCV treatment approaches into everyday Ryan White-funded HIV primary care, increasing the number of sites that can deliver HCV treatment within HIV care and identifying which real-world implementation strategies work best in Ryan White clinical environments.
Why does HRSA emphasize integrating HCV treatment into HIV primary care?
The announcement notes that HCV treatment has historically been underused because many clinics lack the staffing, resources, infrastructure, or clinical capacity to offer it routinely. This initiative is meant to address those gaps by supporting implementation of successful models in standard HIV primary care settings funded by Ryan White.
Who is this program intended to serve?
The focus is on improving access to HCV treatment for underserved people living with HIV who receive care through Ryan White-funded providers.
What types of activities does the grant support?
Funding supports organizations that will implement and evaluate existing successful HCV treatment interventions or care models within Ryan White-funded HIV primary care. Awardees are expected to both deliver services and generate evidence and practical guidance for other Ryan White providers.
What does it mean that these are “demonstration sites�
Demonstration sites are expected to do more than provide care. They must implement a model and document how it works in practice, participate in evaluation activities, and produce information and guidance that other Ryan White providers can use to replicate or adapt the approach.
What evaluation responsibilities are required of participating sites?
Participating sites are required to engage in both local and multi-site evaluations. This includes collecting process and outcome data and other relevant information showing how the adopted model performs in a Ryan White HIV primary care context.
What kinds of evaluation data are applicants expected to collect?
The opportunity specifies collecting process and outcome data and other relevant information, including information on effectiveness and costs, to help the Ryan White community understand resources required, operational steps involved, and clinical outcomes achieved when HCV treatment is integrated into HIV care.
Is documenting and sharing the model a required deliverable?
Yes. A major deliverable is a strong plan to document the approach in a way that can be replicated. Applicants must propose how they will compile lessons learned and clearly describe best practice models that can be shared with other Ryan White grantees and HIV medical providers.
What is required for dissemination of results and materials?
Applicants need a practical dissemination plan for providing complete documentation of their best practice model to HRSA’s HIV/AIDS Bureau and sharing it nationally across the Ryan White community, with the explicit goal of supporting replication and integration into other sites.
Who is eligible to apply?
Eligibility is limited to Ryan White HIV/AIDS Program grantees funded under Parts A, B, C, and D, as well as subcontractors or subproviders that receive Ryan White funding through those entities.
What experience must eligible applicants have?
Eligible applicants must have experience delivering core medical services, including HIV primary care, and allowable support services to HIV-positive underserved individuals.
Are any organizations specifically excluded from applying?
Yes. The announcement excludes organizations that are already actively incorporating HCV treatment into HIV primary care using Ryan White funds, or that are already receiving other funding for similar HCV-in-HIV treatment integration work.
How many awards did HRSA anticipate making, and what was the total funding amount?
The opportunity anticipated making 15 awards with an estimated total funding amount of $1,220,000.
Is there a cost sharing or matching requirement?
No. The announcement states there is no cost sharing or matching requirement.
What is the CFDA number associated with this grant?
The opportunity is associated with CFDA number 93.928, identified as Special Projects of National Significance.
What are the key dates listed for this funding opportunity?
Key dates include a posted date of March 4, 2010; an original closing date of April 5, 2010; a revised closing date of April 20, 2010; and an archive date of June 19, 2010.
Where were applicants directed to go for access issues or administrative questions?
Applicants were directed to the HRSA Call Center at CallCenter@HRSA.GOV and the listed phone numbers in the announcement.
Browse more opportunities from the same category: Health
Next opportunity: Malawi Rural Electrification Public Private Partnership (RE PPP) Mini Grid
Previous opportunity: Notice of Intent Single Source Award Monitoring Activities Redwood Creek Retoration
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for HRSA 10 090
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (HRSA 10 090) also looked into and applied for these:
| Funding Opportunity |
|---|
| Poison Center Support and Enhancement Grant Program, Incentive Grants Apply for HRSA 10 051 Funding Number: HRSA 10 051 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Improving HIV Prevention Initiatives in Communities in the Republic of Zambia under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10109 Funding Number: CDC RFA PS10 10109 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
| ARRA CHARN Central Data Management Coordination Center Apply for HRSA 10 206 Funding Number: HRSA 10 206 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| EMSC Targeted Issue Grants Apply for HRSA 10 062 Funding Number: HRSA 10 062 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| Global Partnerships with Non Governmental Organizations (NGO s) Apply for CDC FOA GH10 1003 Funding Number: CDC FOA GH10 1003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| AETC National Multicultural Center Apply for HRSA 10 149 Funding Number: HRSA 10 149 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| NIAID Advanced Technology SBIR (NIAID AT SBIR R43/R44) Apply for PA 10 123 Funding Number: PA 10 123 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| NIAID Advanced Technology STTR (NIAID AT STTR R41/R42) Apply for PA 10 124 Funding Number: PA 10 124 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHLBI Research Centers at Minority Serving Institutions (P30) Apply for RFA HL 11 019 Funding Number: RFA HL 11 019 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Laboratory Technical Implementation Assistance for Public Health Cooperative Agreement Program Apply for CDC RFA HK10 1001ARRA10 Funding Number: CDC RFA HK10 1001ARRA10 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,000,000 |
| Basic/Core Area Health Education Centers Apply for HRSA 10 116 Funding Number: HRSA 10 116 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Model State Supported Area Health Education Centers Apply for HRSA 10 117 Funding Number: HRSA 10 117 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Strengthening HIV Strategic Information Activities in the Central Asian Republics of Kazakhstan, Kyrgyz Republic, Tajikistan, Turkmenistan, and Uzbekistan Under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1073 Funding Number: CDC RFA PS10 1073 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Scaling up Integrated, Effective and Sustainable Services for the Prevention of Mother to Child HIV Transmission (PMTCT) in the Republic of Uganda under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1021 Funding Number: CDC RFA PS10 1021 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,500,000 |
| Strengthening HIV and Co infection Prevention Activities in Central Asian Republics of Kazakhstan, Kyrgyz Republic, Tajikistan, Turkmenistan, and Uzbekistan Under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1074 Funding Number: CDC RFA PS10 1074 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Strengthening TB/HIV activities in the Central Asian Republics of Kazakhstan, Kyrgyz, Tajikistan, Turkmenistan, and Uzbekistan under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1089 Funding Number: CDC RFA PS10 1089 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| FY10 Promote, Support and Build Capacity in the Medical Reserve Corps Apply for SG MRC 10 001 Funding Number: SG MRC 10 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $5,650,000 |
| Strengthening HIV/AIDS Prevention for Most at Risk Populations in Namibia Apply for 674 10 0027 Funding Number: 674 10 0027 Agency: South Africa USAID Pretoria Category: Health Funding Amount: $5,400,000 |
| HIV prevention activities in target communities in Zambia Apply for 611 2010 09AMENDMENT01 Funding Number: 611 2010 09AMENDMENT01 Agency: Zambia USAID Lusaka Category: Health Funding Amount: $4,400,000 |
| Tribal Self Governance Program Negotiation Cooperative Agreement Apply for HHS 2010 IHS TSGN 0001 Funding Number: HHS 2010 IHS TSGN 0001 Agency: Indian Health Service Category: Health Funding Amount: $30,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "HRSA 10 090", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.